Judge Breathes 6 Months Of Life Into AstraZeneca Patent
A day after hearing arguments from Mylan lawyers that AstraZeneca should be bound to a January 2023 expiration date of a patent protecting the blockbuster asthma treatment Symbicort, a federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article